First opioid use disorder screening test approved by FDA
The Food and Drug Administration of the United States gave its approval on Tuesday to a novel tool that makes use of genetic testing to assist in determining whether or not particular individuals are at risk of developing opioid use disorder. Adults who are contemplating a short-term course of oral opioid pain drugs, such as … Read more